Amanote Research
Register
Sign In
Are Improper Kinetic Models Hampering Drug Development?
doi 10.7287/peerj.preprints.521v1
Full Text
Open PDF
Abstract
Available in
full text
Date
October 2, 2014
Authors
Ryan Walsh
Publisher
PeerJ
Related search
Functional GI Disorders: From Animal Models to Drug Development
Gut
Gastroenterology
A Novel ZnO Nanoparticle as Drug Nanocarrier in Therapeutic Applications: Kinetic Models and Error Analysis
Journal of the Turkish Chemical Society, Section A: Chemistry
Chemistry
Kinetic Models of Micelles Formation
Colloids and Surfaces A: Physicochemical and Engineering Aspects
Surfaces
Colloid
Interfaces
Theoretical Chemistry
Surface Chemistry
Physical
Drug Development for Alzheimer's Disease: Where Are We Now and Where Are We Headed?
The American Journal of Geriatric Pharmacotherapy
Using Genetically Modified Rodent Models in Drug Development to Explore Target Physiology and Potential Drug Effects
Veterinary Pathology
Veterinary
Protein Folded States Are Kinetic Hubs
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
The ERG in Drug Development: Translation From Animal Models to Human
Documenta Ophthalmologica
Ophthalmology
Sensory Systems
Physiology
The Gap Between Cell and Animal Models: Nanoparticle Drug-Delivery Development and Characterization Using Microtissue Models
Therapeutic Delivery
Pharmaceutical Science
Factors Hampering Innovation in Small Firms